IL6 and non-small cell lung carcinoma: Additionally, analysis of the histological subtypes of NSCLC identified that IL-6-C-allele carriers apparently elevated the odds of AC under the dominant model (adjusted the, OR 2.97, p = 0.003, CC + GC vs. GG).